We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results:1-10 of 16

Holstering the hired guns: the medical expert’s duty is to the court, not the litigant
  • Gowling WLG
  • USA
  • October 13 2011

At issue before Master Short was a motion by the plaintiff for an undertaking requiring the defendant to make concurrent disclosure of any medical surveillance provided to its expert to the plaintiff.


FDA approves guidelines to inform doctors of "off-label uses" for medicine and medical devices
  • Gowling WLG
  • USA
  • January 19 2009

The United States Food and Drug Administration (FDA) recently finalized guidelines which will allow pharmaceutical companies to inform doctors about unapproved uses of medicines and medical devices.


FDA clinical trial regulations - "Sentinal System"
  • Gowling WLG
  • USA
  • May 29 2008

On Thursday May 22, 2008, U.S. health officials announced that the FDA will implement a proactive system designed to help identify dangers associated with prescription drugs and medical devices that are currently on the market.


PDUFA reauthorization package clears first hurdle
  • Gowling WLG
  • USA
  • October 4 2007

The United States' House of Representative recently passed the authorization of the Prescription Drug User Fee Act (PDUFA).


Scott E. Foster
  • Gowling WLG




Jeff Beedell
  • Gowling WLG

D. Lynne Watt
  • Gowling WLG